Treatment of Mature Cystic Teratoma of the Ovary
Fertility-sparing surgery (cystectomy or unilateral salpingo-oophorectomy) is the treatment of choice for mature cystic teratomas, with no adjuvant chemotherapy required, as these are benign tumors. 1
Surgical Approach
Patient Age and Fertility Considerations
For reproductive-age women:
- Perform fertility-sparing surgery with either ovarian cystectomy or unilateral salpingo-oophorectomy 1
- Avoid radical surgery and full staging procedures—these are unnecessary and inappropriate for benign mature teratomas 1
- No systematic biopsy of the contralateral ovary is needed when it appears macroscopically normal 2
For postmenopausal women:
- Consider bilateral salpingo-oophorectomy with hysterectomy due to higher risk of malignant transformation (1.4% overall, but increases with age) 3, 4
- The risk of malignancy is the key decision point—not the size of the tumor 3
Laparoscopic vs. Open Surgery
Laparoscopy is the gold standard approach for mature cystic teratomas across a broad size range 5, 6. The evidence shows:
- Laparoscopic management is feasible even for giant teratomas (up to 20 cm) when performed with appropriate expertise 5
- Critical technique requirements to prevent chemical peritonitis:
- Spillage risk is extremely low (2.2%) with proper technique, and chemical peritonitis is exceedingly rare when lavage is performed 5, 6
Cystectomy vs. Oophorectomy Decision Algorithm
Choose cystectomy when:
- Young women with single small cyst
- Strong fertility preservation needs
- Benign appearance on imaging
Choose oophorectomy when:
- Larger cysts where ovarian tissue preservation is not feasible
- Multiple or bilateral cysts
- Postmenopausal status
- Any concern for malignant transformation 6
The decision should prioritize fertility preservation in younger women while recognizing that oophorectomy may be technically necessary for larger lesions 6.
No Adjuvant Therapy Required
Mature cystic teratomas require no adjuvant chemotherapy or radiation 1. This distinguishes them from immature teratomas, which may require platinum-based chemotherapy depending on grade and stage 2.
About two-thirds of germ cell tumors are stage I, and for mature teratomas specifically, surgery alone with careful follow-up is the complete treatment 1.
Surveillance Considerations
While most cases require surgical removal, surveillance may be appropriate in highly selected cases 6:
- Very small cysts in asymptomatic patients
- Patients with significant surgical risk
- Clear benign imaging characteristics
However, given the 10.7% complication rate (including 4.9% torsion risk) and the small but real malignancy risk, most patients benefit from surgical removal 3.
Key Clinical Pitfalls to Avoid
Do not perform full staging procedures (lymph node dissection, multiple biopsies)—the efficacy of salvage treatment makes this unnecessary 1
Do not avoid laparoscopy based on size alone—with proper containment techniques, even large teratomas can be managed laparoscopically 5
Do not routinely biopsy the contralateral ovary—bilaterality occurs in 13.2% of cases but will be detected on imaging if present 3
Do not give adjuvant chemotherapy—mature teratomas are benign and chemotherapy provides no benefit 1
Watch for malignant transformation markers: elevated tumor markers (especially in older women), solid components on imaging, rapid growth—these warrant more aggressive surgical approach 3, 4